UDG Healthcare Public Limited Co. Notice of Q3 2017 Trading Update (9164K)
July 13 2017 - 2:00AM
UK Regulatory
TIDMUDG
RNS Number : 9164K
UDG Healthcare Public Limited Co.
13 July 2017
13 July 2017
UDG Healthcare plc
Notice of Q3 2017 Trading Update
UDG Healthcare plc ("UDG Healthcare" or "Group"), a leading
international healthcare services provider, will issue a trading
update for the third quarter to 30 June 2017 at 7.00am (BST) on
Thursday, 3 August 2017.
The Company will also host a conference call for investors and
analysts at 8.30am (BST) on Thursday, 3 August 2017 to discuss the
statement. The dial-in details are as follows:
Standard International +44 (0) 20 3003
Access 2666
------------------------ ----------------
UK Toll Free 0808 109 0700
------------------------ ----------------
+353 (0) 1 436
Ireland 0959
------------------------ ----------------
Password UDG Healthcare
------------------------ ----------------
A playback facility will be available for seven days on +44 (0)
20 8196 1998. The access code for the replay will be 4912553#.
For further information, please contact:
Keith Byrne
Head of Investor Relations, Strategy & Corporate
Communications
UDG Healthcare plc
Tel: +353-1-468-9000
Lisa Kavanagh / Jack Hickey / Nick Brown
Powerscourt
Tel: +44-207-250-1446
Email: udghealthcare@powerscourt-group.com
About UDG Healthcare plc:
UDG Healthcare plc (LON: UDG) is a leading international partner
of choice delivering commercial, clinical, communications and
packaging services to the healthcare industry, employing almost
8,000 people with operations in 23 countries and delivering
services in over 50 countries.
UDG Healthcare plc operates across three divisions: Ashfield,
Sharp and Aquilant.
Ashfield is a global leader in commercialisation services for
the pharmaceutical and healthcare industry, operating across two
broad areas of activity: commercial & clinical services, and
communications services. It focuses on supporting healthcare
professionals and patients at all stages of the product life cycle.
The division provides field and contact centre sales teams,
healthcare communications, patient support, audit, advisory,
medical information and event management services to over 300
healthcare companies.
Sharp is a global leader in contract commercial packaging and
clinical trial packaging services for the pharmaceutical and
biotechnology industries, operating from state of the art
facilities across the US and Europe. Sharp is also a world leader
in 'Track and Trace' serialisation services, which will require all
prescription drugs to have a unique serial code for authentication
and traceability.
Aquilant is a leading provider of outsourced sales, marketing,
distribution and engineering services to the medical and scientific
sectors in the UK, Ireland and the Netherlands.
The company is listed on the London Stock Exchange and is a
constituent of the FTSE 250.
For more information please go to: www.udghealthcare.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORRTMFTMBJBBTR
(END) Dow Jones Newswires
July 13, 2017 02:00 ET (06:00 GMT)
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Apr 2023 to Apr 2024